The weight loss qualification criteria follow the Wegovy label
When: Appetite is controlled Insulin sensitivity improves Mitochondria function efficiently The body doesnt fight fat loss It supports it
Currently under investigation for obesity, type 2 diabetes, and metabolic liver diseases
So basically, everything surrounding obesity-related heart failure with preserved ejection fraction was improved with active therapy. No Effect on Other Heart Measurements While the reduction in LV mass and fat was significant, tirzepatide didnt affect: LV end-systolic volume LV function Left atrial (LA) volumes and function In another recent study, the SELECT trial, the GLP-1 semaglutide did show an impact on LA volumes and other markers of heart function, but no effect on LV mass
TEXT ON-SCREEN: PREP: Attach the needle LAURA: Next I put on a needle
While the prevalence of these conditions is expected to be lower in fully underwritten insured populations compared to the general population, no population including countries in Asia with lower prevalence is immune to these global trends